Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$21,987,581
+$5,691,187 QoQ
Shares Held
174,035
+48.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#316
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ASR Vermogensbeheer N.V. holds $587,868,942 across 10 Drug Manufacturers - General names. GILD ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
142,153 | $170,502,587 | |
| 2 | AZN |
Astrazeneca PLC
|
862,996 | $163,641,301 | |
| 3 | JNJ |
Johnson & Johnson
|
288,233 | $73,202,535 | |
| 4 | ABBV |
AbbVie Inc.
|
194,041 | $48,828,477 | |
| 5 | MRK |
Merck & Co., Inc.
|
275,102 | $35,350,607 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
468,931 | $27,019,804 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
174,035 | $21,987,581 | |
| 8 | PFE |
Pfizer Inc
|
845,613 | $20,362,361 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,987,581 | 174,035 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $16,296,394 | 116,929 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $13,974,439 | 113,854 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $11,902,197 | 107,227 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $11,928,503 | 107,590 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $11,688,271 | 104,313 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||